Benzoimidazol-2-ylpyrimidines and pyrazines as modulators of the histamine H4 receptor, pharmaceutical composition and use
Номер патента: NO341523B1
Опубликовано: 27-11-2017
Автор(ы): Christopher M Mapes, Daniel J Pippel, David E Kindrachuk, James P Edwards, Jennifer D Venable
Принадлежит: Janssen Pharmaceutica NV
Опубликовано: 27-11-2017
Автор(ы): Christopher M Mapes, Daniel J Pippel, David E Kindrachuk, James P Edwards, Jennifer D Venable
Принадлежит: Janssen Pharmaceutica NV
Реферат: Det beskrives benzoimidazol-2-ylpyrimidiner og -pyraziner. Det beskrives videre farmasøytiske preparater inneholdende disse. Videre beskrives fremgangsmåter for behandling av sykdomstilstander, forstyrrelser og forhold som er mediert av H4-reseptoraktivitet inkludert allergi, astma, autoimmune sykdommer og pruritt. Benzoimidazol-2-ylpyrimidines and pyrazines are disclosed. Further, pharmaceutical compositions containing these are described. Also described are methods for treating disease states, disorders and conditions mediated by H4 receptor activity including allergy, asthma, autoimmune diseases and pruritis.
Parp inhibitor, pharmaceutical composition comprising same, and use thereof
Номер патента: AU2022411308A1. Автор: Yuan Tian,Yongqi Deng,Shijun ZHU,Yanlin JIA. Владелец: Keythera Suzhou Bio Pharmaceuticals Co Ltd. Дата публикации: 2024-08-01.